OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment

Autor: Betul Bozkurt Bulakcı, Aynur Daglar Aday, Basak Gurtekin, Akif Selim Yavuz, Sukru Ozturk, Kivanc Cefle, Ayse Palanduz, Sukru Palanduz
Rok vydání: 2022
Předmět:
Zdroj: Indian Journal of Hematology and Blood Transfusion. 38:668-674
ISSN: 0974-0449
0971-4502
Popis: The introduction of tyrosine kinase inhibitors (TKI) has resulted in a significant improvement in the treatment of CML patients. However, some CML patients are resistant to imatinib therapy, the initial TKI therapy in the CML. Therefore, it is important to find prognostic markers for resistance. The
Databáze: OpenAIRE
Externí odkaz: